Company Overview
Snapshot
Founded in December 2022 by Liat Kaplan, Aviv Kaplan, and David Avraham, WiSP operates with 11–50 employees. The company is in its Pre-Funding stage and received a $100,000 investment from Tel Aviv University in August 2023, following a startup competition award.
Business overview
WiSP is a Health Tech & Life Sciences company focused on developing advanced drug detection solutions. The company leverages Raman spectroscopy, a non-destructive analytical technique, to identify the molecular composition of substances. WiSP's core technology utilizes laser light to produce unique spectral fingerprints, enabling precise and instant detection of drugs without altering the sample. The system integrates artificial intelligence to continuously enhance its algorithms, improving accuracy and speed over time. WiSP aims to serve markets focused on safety, including consumers in recreational and lifestyle settings, as well as educational and academic institutions.
Strategic signal
In August 2023, WiSP secured a $100,000 investment from Tel Aviv University after winning a startup competition. This investment validates the potential of WiSP's technology to address a critical safety concern and signals strong academic and early-stage investor confidence in its innovative approach to drug detection. The funding supports the company's efforts to miniaturize its desktop prototype and develop a mobile-compatible solution, indicating a clear path toward product development and market entry.
Log in to access full profile ›Company Intelligence Q&A
- What is WiSP's core technology for drug detection?
- WiSP utilizes Raman spectroscopy, a non-destructive analytical technique, to identify the molecular composition of substances. This technology uses laser light to create a unique spectral fingerprint for precise drug identification.
- When was WiSP founded and by whom?
- WiSP was founded in December 2022 by Liat Kaplan, Aviv Kaplan, and David Avraham.
- What was a significant early investment received by WiSP?
- In August 2023, WiSP received a $100,000 investment from Tel Aviv University after winning a startup competition.
- How does WiSP enhance its drug detection algorithms?
- WiSP employs artificial intelligence to analyze data collected by its system, continuously enhancing algorithms for improved accuracy and speed over time.
- What are WiSP's next steps in product development?
- WiSP is working on miniaturizing its desktop prototype and developing a mobile-compatible version of its drug detection technology.